These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 19525483)

  • 1. Estimating progression rates for human papillomavirus infection from epidemiological data.
    Jit M; Gay N; Soldan K; Hong Choi Y; Edmunds WJ
    Med Decis Making; 2010; 30(1):84-98. PubMed ID: 19525483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
    Gauthier A; Martín-Escudero V; Moore L; Ferko N; de Sanjosé S; Pérez-Escolano I; Catalá-López F; Ferrer E; Bosch FX
    Eur J Public Health; 2008 Dec; 18(6):674-80. PubMed ID: 18641420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R; Hildenbrand R
    Eur J Cancer Prev; 2009 Aug; 18(4):307-15. PubMed ID: 19436214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between human papillomavirus and Epstein-Barr virus infections in relation to age of patients with cervical adenocarcinoma.
    Lau HY; Twu NF; Chen PC; Lai CR; Juang CM; Yen MS; Chao KC
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):370-4. PubMed ID: 20045757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province].
    Zhao F; Li N; Ma J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Oct; 22(5):375-8. PubMed ID: 11769697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus.
    Bogaards JA; Xiridou M; Coupé VM; Meijer CJ; Wallinga J; Berkhof J
    Am J Epidemiol; 2010 Apr; 171(7):817-25. PubMed ID: 20231211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma.
    Khan S; Jaffer NN; Khan MN; Rai MA; Shafiq M; Ali A; Pervez S; Khan N; Aziz A; Ali SH
    Int J Infect Dis; 2007 Jul; 11(4):313-7. PubMed ID: 17291804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening.
    Ralston Howe E; Li Z; McGlennen RC; Hellerstedt WL; Downs LS
    Am J Obstet Gynecol; 2009 Mar; 200(3):245.e1-7. PubMed ID: 19254582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of retinoid deficiency and estrogens as cofactors in cervical cancer.
    Gariglio P; Gutiérrez J; Cortés E; Vázquez J
    Arch Med Res; 2009 Aug; 40(6):449-65. PubMed ID: 19853185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.